DE20311240U1 - Zusammensetzung zur Förderung der geistigen Leistung - Google Patents

Zusammensetzung zur Förderung der geistigen Leistung

Info

Publication number
DE20311240U1
DE20311240U1 DE20311240U DE20311240U DE20311240U1 DE 20311240 U1 DE20311240 U1 DE 20311240U1 DE 20311240 U DE20311240 U DE 20311240U DE 20311240 U DE20311240 U DE 20311240U DE 20311240 U1 DE20311240 U1 DE 20311240U1
Authority
DE
Germany
Prior art keywords
phenylalanine
composition
choline
isoleucine
valine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE20311240U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SPORTMEDIZIN TEAM VERTRIEBS GM
Original Assignee
SPORTMEDIZIN TEAM VERTRIEBS GM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPORTMEDIZIN TEAM VERTRIEBS GM filed Critical SPORTMEDIZIN TEAM VERTRIEBS GM
Priority to DE20311240U priority Critical patent/DE20311240U1/de
Publication of DE20311240U1 publication Critical patent/DE20311240U1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt

Claims (2)

1. Zusammensetzung zur Förderung der geistigen Leistung, gekennzeichnet durch die Kombination der folgenden Wirkstoffe: L-Leucin, L-Valin, L- Isoleucin, L-Arginin, L-Asparaginsäure, Cholin und Phenylalanin.
2. Zusammensetzung nach Anspruch 1, dadurch gekennzeichnet, daß das Phenylalanin in einer solchen Menge darin enthalten, daß in einer Tagesdo­ sis der Zusammensetzung zwischen 100 und 200 mg des Phenylalanins, vorzugsweise 150 mg, enthalten sind.
DE20311240U 2003-07-21 2003-07-21 Zusammensetzung zur Förderung der geistigen Leistung Expired - Lifetime DE20311240U1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20311240U DE20311240U1 (de) 2003-07-21 2003-07-21 Zusammensetzung zur Förderung der geistigen Leistung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE20311240U DE20311240U1 (de) 2003-07-21 2003-07-21 Zusammensetzung zur Förderung der geistigen Leistung

Publications (1)

Publication Number Publication Date
DE20311240U1 true DE20311240U1 (de) 2003-09-25

Family

ID=28685648

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20311240U Expired - Lifetime DE20311240U1 (de) 2003-07-21 2003-07-21 Zusammensetzung zur Förderung der geistigen Leistung

Country Status (1)

Country Link
DE (1) DE20311240U1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034932A2 (en) * 2003-10-07 2005-04-21 Professional Dietetics S.R.L. Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
WO2007031725A1 (en) * 2005-09-14 2007-03-22 Mars Uk Limited Food supplement
WO2012085954A1 (en) * 2010-12-21 2012-06-28 D Aniello Antimo Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034932A2 (en) * 2003-10-07 2005-04-21 Professional Dietetics S.R.L. Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
WO2005034932A3 (en) * 2003-10-07 2005-06-30 Professional Dietetics Srl Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
US7973077B2 (en) 2003-10-07 2011-07-05 Professional Dietetics S.R.L. Amino acid based compositions for the treatment of pathological conditions distinguised by insufficient mitochondrial function
US8211944B2 (en) 2003-10-07 2012-07-03 Professional Dietetics S.R.L. Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
US8324278B2 (en) 2003-10-07 2012-12-04 Determinants Of Metabolism Research Laboratory S.R.L. Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
WO2007031725A1 (en) * 2005-09-14 2007-03-22 Mars Uk Limited Food supplement
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
WO2012085954A1 (en) * 2010-12-21 2012-06-28 D Aniello Antimo Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease

Similar Documents

Publication Publication Date Title
AU761947B2 (en) Skin and tissue care and/or treatment agent
JP2003513039A5 (de)
EP1723851A3 (de) Synergistische herbizide Mischungen, die ein Derivat eines Suflonylharnstoffes und ein Dinitroanilin enthalten
AR047551A1 (es) Compuestos activos antritranspirantes de aluminio/ zirconio / glicina, estabilizados con betaina
CA2069917A1 (en) Carnitine supplemented cat fish diet
ATE401089T1 (de) Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
MXPA01006917A (es) Composicion topica que comprende n-acetilaldosaminas o acidos n-acetilaminos.
ECSP066917A (es) Bioconversión esteroselectiva de dinitrilos alifáticos en ácidos cianocarboxílicos
MY166631A (en) Orally administrable composition for improving skin quality
CA2528649A1 (en) Analgesic and anti-inflammatory patch
DE20311240U1 (de) Zusammensetzung zur Förderung der geistigen Leistung
CA2332915A1 (en) Compositions comprising gaba analogs and caffeine
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
DK0769901T3 (da) To- og trekomponent svampedræbende blandinger
PE20010331A1 (es) Una combinacion sinergetica: gabapentina y pregabalina
IL71650A (en) Pharmaceutical compositions comprising a combination of ypsilon-vinyl gaba together with a glycine derivative
DE60115944D1 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-karnitin und alkanoyl-l-karnitin mit taurinchlorid enthalten
ATE308892T1 (de) Ursolsäure und oleanolsäure enthaltende mischungen
Nurrani Local wisdom in the utilization of medicine plants by community around Aketajawe Lolobata National Park, North Maluku Province
DE20209721U1 (de) Pflegesalbe zur Behandlung trockener, stark beanspruchter und durch Strahlen geschädigte Haut
US6733794B1 (en) Topical composition for antiseptic and analgesic purposes
FR2911505A1 (fr) Lotion capillaire
RU2002116010A (ru) Антисептическое средство "АХДЕЗ 3000"
DE20110381U1 (de) Schnürschutz, Schnürfixierung und Abdeckung
GEP20053571B (en) Method for Treatment of Ascosferose

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20031030

R156 Lapse of ip right after 3 years

Effective date: 20070201